Armata Pharmaceuticals, Inc.
ARMP
$5.41
-$0.41-7.05%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 23.95M | 4.75M | 8.69M | 14.76M | 4.33M |
| Total Receivables | 2.53M | 47.00K | 472.00K | 759.00K | 2.17M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 673.00K | 1.15M | 1.51M | 1.42M | 1.02M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 27.16M | 5.95M | 10.67M | 16.93M | 7.52M |
|
|
|||||
| Total Current Assets | 27.16M | 5.95M | 10.67M | 16.93M | 7.52M |
| Net Property, Plant & Equipment | 44.11M | 45.18M | 46.11M | 52.48M | 53.16M |
| Long-term Investments | 3.49M | 3.49M | 3.49M | 3.49M | 3.49M |
| Goodwill | 3.49M | 3.49M | 3.49M | 3.49M | 3.49M |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 15.19M | 15.19M | 16.62M | 16.62M | 16.62M |
| Total Assets | 89.95M | 69.80M | 76.88M | 89.52M | 80.79M |
|
|
|||||
| Total Accounts Payable | 1.19M | 660.00K | 921.00K | 1.28M | 965.00K |
| Total Accrued Expenses | 2.71M | 3.60M | 2.98M | 2.56M | 2.16M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 246.11M | 4.59M | 4.56M | 135.61M | 116.82M |
| Total Finance Division Other Current Liabilities | 195.00K | 372.00K | 487.00K | 503.00K | 137.00K |
| Total Other Current Liabilities | 195.00K | 372.00K | 487.00K | 503.00K | 137.00K |
| Total Current Liabilities | 250.20M | 9.23M | 8.95M | 139.95M | 120.09M |
|
|
|||||
| Total Current Liabilities | 250.20M | 9.23M | 8.95M | 139.95M | 120.09M |
| Long-Term Debt | 42.02M | 342.90M | 256.92M | 15.24M | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 25.82M | 26.18M | 26.53M | 26.84M | 27.13M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.08M | 3.08M | 3.08M | 3.08M | 3.08M |
| Total Liabilities | 321.12M | 381.39M | 295.48M | 185.10M | 150.29M |
|
|
|||||
| Common Stock & APIC | 311.57M | 305.29M | 282.94M | 281.65M | 281.06M |
| Retained Earnings | -542.74M | -616.88M | -501.53M | -377.24M | -350.56M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -231.17M | -311.59M | -218.60M | -95.59M | -69.50M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -231.17M | -311.59M | -218.60M | -95.59M | -69.50M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -231.17M | -311.59M | -218.60M | -95.59M | -69.50M |
|
|
|||||